• About us
• Contact

Advertisement

Organisation › Details

Metabolomic Technologies Inc. (MTI)

Metabolomic Technologies Inc. (MTI) is a spin-off company from the University of Alberta. The company was formed by Drs. Haili Wang and Richard Fedorak to develop advanced metabolomic-based diagnostic tests for the management of chronic diseases or 'high value' diagnostics. MTI's initial focus is on developing highly novel, patented, metabolomic-based diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC). Their flagship product, PolypDx™, a spot urine diagnostic test, innovatively offers significantly higher sensitivity in detecting adenomatous polyps than existing commercial tests, and thus significantly advances the prevention of CRC. *

 

	Start	2010-05-01 splitoff
	Predecessor	University of Alberta
	Industry	diagnostics (medical/biological)
	Industry 2	metabolomics
	Person	Joseph, Reg (Invitrogen 200606)
	Region	Edmonton, AB
	Country	Canada
	Street	10230 Jasper Avenue Suite 4227
	City	T5J 4P6 Edmonton, AB
	Tel	+1-780-245-0865
		Address record changed: 2020-12-02
Basic data	Employees	A: 1 to 10 (2013-12-01)
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.